Christian Trépo

17.8k total citations · 5 hit papers
275 papers, 12.9k citations indexed

About

Christian Trépo is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Christian Trépo has authored 275 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Epidemiology, 189 papers in Hepatology and 59 papers in Infectious Diseases. Recurrent topics in Christian Trépo's work include Hepatitis B Virus Studies (171 papers), Hepatitis C virus research (157 papers) and Liver Disease Diagnosis and Treatment (92 papers). Christian Trépo is often cited by papers focused on Hepatitis B Virus Studies (171 papers), Hepatitis C virus research (157 papers) and Liver Disease Diagnosis and Treatment (92 papers). Christian Trépo collaborates with scholars based in France, United States and Germany. Christian Trépo's co-authors include Fabien Zoulim, Janice K. Albrecht, Christian Pichoud, Isabelle Chemin, John C. Hoefs, Mitchell L. Shiffman, Stuart C. Gordon, Karen L. Lindsay, Pierre Pradat and Ferruccio Bonino and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Christian Trépo

269 papers receiving 12.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

1998 1.1k citations Gary L. Davis, Rafael Esteban et al. New England Journal of Medicine profile →
Infection of a human hepatoma cell line by hepatitis B virus

2002 996 citations Christian Trépo et al. profile →
Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C

2002 775 citations Christian Trépo, Janice K. Albrecht et al. Gastroenterology profile →
Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

1977 699 citations Mario Rizzetto, Sarino Aricò et al. Gut profile →
A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C

2001 507 citations Christian Trépo, Mitchell L. Shiffman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christian Trépo France	52	9.4k	9.0k	2.0k	1.4k	768	275	12.9k
Sugantha Govindarajan United States	55	6.7k 0.7×	7.9k 0.9×	2.0k 1.0×	1.0k 0.8×	797 1.0×	180	10.4k
Ferruccio Bonino Italy	56	14.0k 1.5×	14.2k 1.6×	1.4k 0.7×	1.1k 0.8×	1.0k 1.3×	329	17.0k
Francesco Negro Switzerland	64	12.2k 1.3×	12.4k 1.4×	1.5k 0.7×	1.4k 1.0×	833 1.1×	311	16.0k
C. Trépo France	46	9.1k 1.0×	9.4k 1.0×	1.2k 0.6×	669 0.5×	737 1.0×	200	11.2k
Geoffrey Dusheiko United Kingdom	60	14.6k 1.6×	15.1k 1.7×	2.4k 1.2×	1.1k 0.8×	1.6k 2.0×	285	18.6k
T. Jake Liang United States	68	9.1k 1.0×	8.9k 1.0×	1.6k 0.8×	2.3k 1.6×	1.7k 2.3×	195	13.2k
David R. Gretch United States	53	7.9k 0.8×	9.1k 1.0×	1.0k 0.5×	1.3k 0.9×	1.7k 2.2×	142	12.4k
Stanislas Pol France	71	14.2k 1.5×	15.1k 1.7×	3.1k 1.6×	925 0.7×	1.1k 1.4×	484	18.9k
Marion G. Peters United States	48	7.0k 0.7×	7.0k 0.8×	1.4k 0.7×	605 0.4×	1.1k 1.4×	211	9.9k
Robert G. Gish United States	68	12.4k 1.3×	12.4k 1.4×	1.7k 0.9×	1.4k 1.0×	721 0.9×	373	16.0k

Countries citing papers authored by Christian Trépo

Since Specialization

Citations

This map shows the geographic impact of Christian Trépo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Trépo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Trépo more than expected).

Fields of papers citing papers by Christian Trépo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Trépo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Trépo. The network helps show where Christian Trépo may publish in the future.

Co-authorship network of co-authors of Christian Trépo

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Trépo. A scholar is included among the top collaborators of Christian Trépo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Trépo. Christian Trépo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pradat, Pierre, Nicolas Voirin, Hans L. Tillmann, Michèle Chevallier, & Christian Trépo. (2007). Progression to cirrhosis in hepatitis C patients: an age‐dependent process. Liver International. 27(3). 335–339. 67 indexed citations

Maynard, M. Travis, Marie‐Claude Gagnieu, Pierre Pradat, Claude Souvignet, & Christian Trépo. (2007). [619] PREDICTION OF SUSTAINED VIROLOGICAL RESPONSE BY RIBAVIRIN PLASMA CONCENTRATION AT WEEK 4 DURING PEGYLATED-INTERFERON/RIBAVIRIN COMBINATION THERAPY IN HCV PATIENTS. Journal of Hepatology. 46. S234–S234. 8 indexed citations

Trabaud, Mary‐Anne, Laurent Cotte, Sophie Lebel‐Binay, et al.. (2007). Variants With Different Mutation Patterns Persist in the Quasispecies of Enfuvirtide-Resistant HIV-1 Population During and After Treatment In Vivo. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(2). 134–144. 7 indexed citations

Voirin, Nicolas, Christian Trépo, Patrick Miailhes, et al.. (2004). Survival in HIV‐infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database. Journal of Viral Hepatitis. 11(6). 559–562. 15 indexed citations

Fournillier, Anne, et al.. (2004). Analysis of B‐lymphocyte differentiation in patients infected with hepatitis C virus. Journal of Medical Virology. 72(4). 566–574. 15 indexed citations

Peters, Marion G., Hie‐Won Hann, Paul Martin, et al.. (2003). Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).. Gastroenterology. 126(1). 91–101. 440 indexed citations

Rabodonirina, Méja, Laurent Cotte, Sylvie Radenne, Emilio Besada, & Christian Trépo. (2003). Microsporidiosis and Transplantation: A Retrospective Study of 23 Cases. Journal of Eukaryotic Microbiology. 50(s1). 583–583. 28 indexed citations

Merle, Philippe, Michèle Chevallier, Olivier Terradillos, et al.. (2001). Preliminary results of interferon-α therapy on woodchuck hepatitis virus-induced hepatocarcinogenesis: possible benefit in female transgenic mice. Journal of Hepatology. 34(4). 562–569. 17 indexed citations

Dumortier, Jérôme, T Bizollon, M. Chevallier, et al.. (1999). Recurrence of hepatocellular carcinoma as a mixed hepatoblastoma after liver transplantation. Gut. 45(4). 622–625. 9 indexed citations

10.

Davis, Gary L., Rafael Esteban, Vinod K. Rustgi, et al.. (1998). Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C. New England Journal of Medicine. 339(21). 1493–1499. 1070 indexed citations breakdown →

11.

Zoulim, Fabien & Christian Trépo. (1997). Virus de l'hépatite B : réplication et mécanismes d'action des antiviraux. Virologie. 1(3). 197–215. 2 indexed citations

12.

Inchauspé, Geneviève, Ludmila Vitvitski, Marian Major, et al.. (1997). Plasmid DNA Expressing a Secreted or a Nonsecreted Form of Hepatitis C Virus Nucleocapsid: Comparative Studies of Antibody and T-Helper Responses Following Genetic Immunization. DNA and Cell Biology. 16(2). 185–195. 98 indexed citations

13.

Cova, Lucyna, et al.. (1994). Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in domestic Chinese ducks. British Journal of Cancer. 69(1). 104–109. 19 indexed citations

14.

Lombard, Martin, Bernard Portmann, J. S. Neuberger, et al.. (1993). Cyclosporin a treatment in primary biliary cirrhosis: Results of a long-term placebo controlled trial. Gastroenterology. 104(2). 519–526. 101 indexed citations

15.

Cova, Lucyna, et al.. (1993). Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in ducks. PubMed. 8. 81–87. 11 indexed citations

16.

Trépo, Christian, et al.. (1993). Specific detection of anti-HBc antibodies with an enzyme immunoassay using recombinant HBcAg and monoclonal antibodies. Journal of Virological Methods. 43(1). 21–30. 3 indexed citations

17.

Godinot, Catherine, et al.. (1988). Use of immunoblotting to characterize the mitochondrial antigens recognized by anti-mitochondrial autoantibodies. Journal of Immunological Methods. 113(1). 61–73. 5 indexed citations

18.

Rizzetto, Mario, Sarino Aricò, O Crivelli, et al.. (1977). Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.. Gut. 18(12). 997–1003. 699 indexed citations breakdown →

19.

Jp, Ortonne, et al.. (1977). [Adult papular acrodermatitis (Gianotti's disease). Report of 3 cases].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 104(3). 190–4. 10 indexed citations

20.

Trépo, Christian, Arie J. Zuckerman, R. Curtis Bird, & Alfred M. Prince. (1974). The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. Journal of Clinical Pathology. 27(11). 863–868. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact